Clinical and molecular epidemiology of beta-hemolytic streptococcal infections in India

Journal of Infection in Developing Countries

Volumn 8, Issue 3, 2014, Pages 297-303

  Mathur, Purva ^a   Bhardwaj, Nidhi ^a   Mathur, Kushal ^a   Behera, Bijayini ^a   Gupta, Gunjan ^a   Kapil, Arti ^a   Singh, Sarman ^a   Misra, Mahesh C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antimicrobial resistance; Beta hemolytic streptococci; emm types; Group A streptococcus; Spe

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL TOXIN; CEFOPERAZONE; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; PENICILLIN G; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SEVERITY; DISK DIFFUSION; EMM GENE; EPSILOMETER TEST; EXOTOXIN GENE; FOLLOW UP; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GROUP A STREPTOCOCCAL INFECTION; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STRANGLES; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; DRUG RESISTANCE, BACTERIAL; GENETIC VARIATION; HEMOLYSIN PROTEINS; HUMANS; INDIA; MACROLIDES; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TETRACYCLINE;

EID: 84896097536     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3216     Document Type: Article

References (22)

1. Musser JM, Shelburne SA (2009) A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest 119: 2455-2463.
2. Vandamme P, Pot B, Falsen E, Kersters K, Devriese LA (1996) Taxonomic study of Lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int J Syst Bacteriol 46: 774-781.
3. Ruoff KL (1988) Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin Microbiol Rev 1: 102-108.
4. Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A Streptococcal virulence. Lancet Infect Dis 3: 191-200.
5. Fischetti VA (1989) Streptococcal M Protein: Molecular Design and Biological Behavior. Clin Microbiol Rev 2: 285-315.
6. Shet A, Kaplan E (2004) Addressing the burden of Group A Streptococcal diseases in India. Ind J Med Pediatr 71: 41-48.
7. Collee JG, Diguid JP, Fraser AG, editors (1996) Mackie and McCartney practical Medical Microbiology, 14thedition. Edinburgh: Churchill Livingstone. 263-273.
8. Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing. 16 suppl. M100-S16. CLSI: Wayne, PA.
9. Clinical Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing. 19 Suppl. M100-S17. CLISI: Wayne, PA.
10. Jing HB, Ning B, Hao H, Zheng YL, Chang D, Jiang W, Jiang YQ (2006) Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol 55: 1101-1107.
11. Rivera A, Rebollo M, Miro E, Mateo M, Navarro F, Gurgui M, Mirelis B, Coll P (2006) Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 55: 1115-1123.
12. Beall B, Facklam R and Thompson T (1996) Sequencing emm-Specific PCR Products for Routine and Accurate Typing of Group A Streptococci. J Clin Microbiol 34: 953-958.
13. Mathur P, Kapil A, Das B (2004) Prevalence of group G & group C streptococci at an Indian tertiary care centre. Indian J Med Res 120: 199-200.
14. Reissmann S, Friedrichs C, Rajkumari R, Itezek A, Fulde M, Rodloff AC, Brahmadathan KN, Chhatwal GS, Nitsche-Schmitz DP (2010) Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India. Emerg Infect Dis 16: 656-663.
15. Bassetti M, Manno G, Collidà A, Ferrando A, Gatti G, Ugolotti, E, Cruciani M, Bassetti D (2000) Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 6: 180-183.
16. York MY, Gibbs L, Perdreau-Remington F, Brooks GF (1999) Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco bay area of northern California. J Clin Microbiol 37: 1727-1731.
17. Brown DF, Hope R, Livermore DM, Brick G, Broughton K, George RC, Reynolds R (2008) Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 62 Suppl. 2: 75-85.
18. Kittang BR, Skrede S, Langeland N, Haanshuus CG, Mylvaganam H (2011) Emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway. Eur J Clin Microbiol Infect Dis 30: 423-433.
19. Hu MC, Walls MA, Stroop SD Reddish MA, Beall B, Dale JB (2002) Immunogenicity of a 26-valent group A Streptococcal vaccine. Infect Immun 70: 2171-2177.
20. Pimtanothai N, Nilgate S, Nunthapisud P (2002) Emm types of Invasive Group A Streptococcal Isolates from Thai Patients at King Chulalongkorn Memorial Hospital from 1995-1999. J Med Assoc Thai 85 Suppl 1: 371-377.
21. Sagar V, Bakshi D K, Nandi S, Ganguly NK, Kumar R, Chakraborti A (2004) Molecular heterogeneity among north Indian isolates of Group A Streptococcus. Lett Appl Microbiol 39: 84-88.
22. Smeesters PR, McMillan DJ, Sriprakash KS, Georgousakis MM (2009) Difference among group A Streptococcus epidemiological landscapes: consequences for M protein-based vaccine? Expert Rev Vaccines 8: 1705-1720.